Translating Hypertension Guidelines Into Scalable Care Pathways

Key Clinical Summary

• Clarifying distinctions among clinical practice guidelines, treatment protocols, and care pathways may improve implementation of hypertension programs in primary care.
• The HEARTS in the Americas initiative integrates the 2021 World Health Organization (WHO) hypertension guideline with simplified treatment protocols and standardized clinical pathways.
• Aligning these tools with health system workflows, resources, and training may strengthen hypertension control and cardiovascular disease prevention.

Cardiovascular disease remains the leading cause of death worldwide, and hypertension is its most important modifiable risk factor. A recent communication on the HEARTS in the Americas initiative highlights that clearer distinctions among clinical practice guidelines, treatment protocols, and care pathways may support more effective implementation of hypertension management programs across health systems.

Study Findings

Drawing on the implementation experience of HEARTS in the Americas—an adaptation of the WHO Global HEARTS Initiative—investigators examined how these 3 tools function together in hypertension control programs. The analysis focuses on their distinct roles in guiding evidence-based clinical decisions while enabling large-scale program implementation.

Clinical practice guidelines serve as the scientific foundation of care. Developed through rigorous evaluation of clinical evidence, these documents provide broad recommendations for diagnosing and treating hypertension. However, the authors note that guidelines are often lengthy and complex, which can limit their usability in routine primary care settings where most hypertension management occurs.

Treatment protocols translate guidelines into simplified, actionable instructions for frontline providers. In the HEARTS model, protocols specify a limited number of medications, standardized dosing, and stepwise titration strategies designed to achieve timely blood pressure control while reducing therapeutic inertia.

Care pathways expand this framework further by embedding treatment protocols into multidisciplinary care delivery workflows. These pathways guide the full continuum of care—from diagnosis to long-term follow-up—while promoting task-sharing among clinicians, nurses, pharmacists, and community health workers. By standardizing key interventions and timelines, pathways aim to reduce variation in practice and improve coordination within health systems.

The HEARTS Clinical Pathway integrates the WHO hypertension pharmacologic guideline with a structured protocol and has been adopted or adapted by most countries participating in the initiative. According to the report, 28 of the 33 countries implementing HEARTS in the region have developed national care pathways aligned with local health system capacities.

Clinical Implications

Hypertension control at scale requires more than clinical knowledge; it requires operational tools that translate evidence into consistent care delivery. The authors emphasize that confusion between guidelines, protocols, and pathways can hinder program design and reduce effectiveness.

Within the HEARTS framework, guidelines define what should be done based on evidence, protocols define how treatment should proceed for most patients, and care pathways organize these recommendations into a coordinated system of care. This layered approach supports standardized management while allowing countries to adapt protocols to local medication availability and health care infrastructure.

Implementation barriers remain at multiple levels of the health system. National-level challenges include governance and financing constraints, while facility-level issues may involve limited infrastructure or workforce shortages. At the clinician level, lack of training, time pressures, or resistance to standardized approaches can affect adoption.

Addressing these barriers requires coordinated leadership, workforce training, and access to essential medicines and validated blood pressure measurement devices.

The authors note that “clinical practice guidelines synthesize the best available evidence into recommendations for broad clinical decision-making,” while treatment protocols and care pathways translate these recommendations into practical tools for frontline providers. They emphasize that clear differentiation among these tools can improve communication, coordination, and evaluation across health systems.

Conclusion

The HEARTS in the Americas initiative illustrates how integrating guidelines, treatment protocols, and care pathways can support large-scale hypertension control. Clarifying the roles of these tools may strengthen health system alignment, improve care consistency, and advance equitable cardiovascular disease prevention across diverse health care settings.

Reference

Ordunez P, Angell SY, DiPette DJ, et al. Translating guidelines, protocols, and care pathways for hypertension into effective program implementation. Am J Hypertens. 2026;39(1):23-27. doi:10.1093/ajh/hpaf103